Paul W. Blavin
Founder presso Mercy Bioanalytics, Inc.
Profilo
Paul W.
Blavin founded Mercy Bioanalytics, Inc. in 2018, where he is working as Vice Chairman from 2023.
Mr. Blavin also founded PWB Value Partners LP.
Mr. Blavin also formerly worked at Blavin & Co., Inc., as Chairman & Chief Executive Officer.
Mr. Blavin received his undergraduate degree from the University of Michigan and Masters Business Admin degree from Harvard Business School.
Posizioni attive di Paul W. Blavin
Società | Posizione | Inizio |
---|---|---|
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Founder | 01/01/2018 |
Precedenti posizioni note di Paul W. Blavin
Società | Posizione | Fine |
---|---|---|
PWB Value Partners LP | Founder | - |
Blavin & Co., Inc.
Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Chairman | - |
Formazione di Paul W. Blavin
University of Michigan | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Blavin & Co., Inc.
Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Finance |
PWB Value Partners LP | |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
- Borsa valori
- Insiders
- Paul W. Blavin